New third-party app connections, more compatible devices and in-clinic Bluetooth uploads to better connect patients and their data with clinicians
MOUNTAIN VIEW, California and GOTHENBURG, Sweden, Sept. 17, 2019 /PRNewswire/ -- Glooko®, the leader in diabetes data management solutions, continues to strengthen its global position with the introduction of several new features and expanded connectivity capabilities for the diasend® by Glooko system at this week's 55th annual meeting of the European Association for the Study of Diabetes (EASD). The additional device integration partnerships, new ways to upload patient data in clinic, and feature enhancements will be unveiled at the September 17-20 meeting in Barcelona.
Increased device compatibility
At EASD, Europe's largest and most prominent diabetes meeting, Glooko will share new device integrations it has developed with two new partners:
- Ypsomed's mylife™ YpsoPump® Insulin Pump* is now compatible with diasend® via app connection to mylife™ Cloud. By linking the two systems together, data flows between them seamlessly and automatically and is easily accessible for both patients and clinicians.
- Basal insulin data from Tandem Diabetes Care's t:slim X2™ – with Basal-IQ® technology can now be viewed in diasend® by uploading it at home or during a clinic consultation along with information from other diabetes devices, then reviewing it in customizable charts, graphs and tables.
Additional ways to upload data in-clinic
At the beginning of 2019, NFC connectivity (near-field communication) was introduced in the hardware of the diasend® by Glooko system, which serves as a "one-stop shop" for patients when visiting their health care provider, because it's able to upload data from numerous devices regardless of brand. Now, BLE (Bluetooth Low Energy) is also added to the mix of ways to upload data to the diasend® solution, providing greater flexibility for the upload process and making clinic/patient interaction even easier. Both NFC and BLE are expected to become increasingly common in diabetes devices during the next couple of years.
"Glooko is pleased to bring additional value to our customers with new data solutions and device integrations on our trusted diasend data management platform," said Russ Johannesson, CEO of Glooko. "It exemplifies the increasing momentum of Glooko solutions, which provide comprehensive patient-based diabetes data to physicians, better connecting them with their patients. Our greater reach with diasend by Glooko enables healthcare professionals to better focus on value-based outcomes for the patients they serve."
Prominent speakers at EASD
On the scientific front, Glooko will offer in-booth presentations from two renowned speakers:
- Professor Roman Hovorka (University of Cambridge) will present on the topic of how the use of closed-loop systems in diabetes management has become increasingly common, which highlights the importance of using an integrated diabetes management system to handle and draw conclusions from data uploads.
- Dr. Dominic Ehrmann (Diabetes Center Mergentheim) will present the results from a multi-center randomized controlled trial, where diasend by Glooko was used to evaluate an education programme of flash glucose monitoring.
"We are proud of the array of diasend by Glooko news that will be showcased at EASD this year, and how it highlights our continuous innovation. We are adding more options to our comprehensive list of compatible devices and introducing new ways for them to function seamlessly with our universal solution," said Anders Sonesson, Global VP and General Manager of Glooko. "As always, we put our users at the heart of everything we do, and these additions will facilitate the patient/clinic interaction from both sides."
*Available in selected European countries.
Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. The Glooko product suite contains the Glooko and diasend® diabetes management solutions, which integrate with many of the leading EHR systems used today. Both systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake. Trusted by the world's leaders in diabetes care, our solutions cover more than 2.2 million people with diabetes and are used in 9,000+ clinic locations in 24 countries across 15 languages. Learn more by visiting www.glooko.com
Marketing Director EMEA/APAC
+46 701 46 10 10
SignalWest Public Relations